.Accept to this week's Chutes & Ladders, our summary of notable management hirings, firings as we...
.Adhering to a bad showing for Lykos Therapeutics' MDMA candidate for trauma at a recent FDA advisor...
.AN2 Therapeutics is actually rethinking its own business in response to dull midphase records, swea...
.Merck & Co. is spending $700 million upfront to test Amgen in a blood cancer cells market. The p...
.With Gilead Sciences about to an FDA choice for its liver ailment drug seladelpar, the business has...
.CEO David Ricks can easily observe the firms establishing tents at basecamp responsible for Eli Lil...
.Bed Liquidators has actually transformed Entero Therapeutics white colored as a sheet. The financia...
.Exelixis is quiting on its cells factor (TF)- targeting antibody-drug conjugate after ending the pr...
.3 full weeks after Roche's Genentech system bowed out an SHP2 prevention deal, Relay Therapeutics h...
.Stoke Therapies' Dravet disorder medicine has actually been freed from a predisposed hold, getting ...